Follow the Milestone Pharmaceuticals Inc. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Operating in the Health Care sector, Milestone Pharmaceuticals Inc. has recorded 24 insider filings. Market capitalisation: €144.4m. The latest transaction was reported on 20 April 2026 (Cession). Among the most active insiders: Oliveto Joseph. All data is openly available.
24
Insider Decl.
n/a
Thresholds
€14m
6 ops.
Buy Volume
€70,972
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Milestone Pharmaceuticals Inc. Strong Buy (bullish), based on 6 analysts. Average price target: US$6.33.
43Σ signal
Buys €14m€70,972 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
8,016 shares@ US$1.120.0047% mcap100.0% of flowCommon SharesSEC:0001209191-22-033336:0
24 of 24 declarations
About Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc. is a biopharmaceutical company focused on developing innovative treatments for cardiovascular diseases. It is listed on NASDAQ under the ticker MIST.